176198-99-5

Basic information

• Product Name: methyl 4-O-[(4-methylphenyl)sulfonyl]-α-D-lyxopyranoside
• Synonyms: methyl 4-O-[(4-methylphenyl)sulfonyl]-α-D-lyxopyranoside
• CAS NO: 176198-99-5
• Molecular Weight: 318.348
• Mol File: 176198-99-5.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: methyl 4-O-[(4-methylphenyl)sulfonyl]-α-D-lyxopyranoside(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 4-O-[(4-methylphenyl)sulfonyl]-α-D-lyxopyranoside(176198-99-5)
• EPA Substance Registry System: methyl 4-O-[(4-methylphenyl)sulfonyl]-α-D-lyxopyranoside(176198-99-5)

Safety Data

• Hazardous Substances Data: 176198-99-5(Hazardous Substances Data)

Upstream product

• 18449-76-8 methyl α-D-lyxopyranoside 
• 98-59-9 p-toluenesulfonyl chloride 
• 60562-98-3 methyl 2,3-O-isopropylidene-α-D-lyxopyranoside 
• 87-72-9 D-lyxose 
• 62819-14-1 methyl 2,3-O-isopropylidene-4-O-[(4-methylphenyl)sulfonyl]-α-D-lyxopyranoside 

Downstream Products

• 58990-26-4 methyl 4-deoxy-β-L-erythro-pentopyranoside 
• 18449-76-8 methyl α-D-lyxopyranoside 
• 188892-82-2 C₂₆H₃₉F₃O₄Si₂ 
• 172939-24-1 6-O-acetyl-3,4-di-O-benzyl-1,5-dideoxy-1,1,1-trifluoro-L-arabino-hexitol 
• 173008-87-2 Acetic acid (3S,4R,5S)-3,4-bis-benzyloxy-6,6,6-trifluoro-5-hydroxy-hexyl ester 
• 1054656-97-1 Acetic acid (3S,4S,5S)-3,4-bis-benzyloxy-6,6,6-trifluoro-5-trifluoromethanesulfonyloxy-hexyl ester 
• 172939-22-9 5-O-acetyl-2,3-di-O-benzyl-4-deoxy-L-erythro-pentose trimethylene dithioacetal 
• 172939-21-8 2,3-di-O-benzyl-4-deoxy-L-erythro-pentose trimethylene dithioacetal 
• 172939-23-0 5-O-acetyl-2,3-di-O-benzyl-4-deoxy-aldehydo-L-erythro-pentose 
• 172939-18-3 methyl 2,3-di-O-benzyl-4-deoxy-β-L-erythro-pentopyranoside 
• 690229-73-3 methyl 3,4-anhydro-β-L-ribopyranoside 
• 95628-43-6 methyl-[O²,O³-dimethyl-O⁴-(toluene-4-sulfonyl)-α-D-lyxopyranoside] 

Relevant articles and documents

Synthesis of fusion-isomeric imidazopyridines and their evaluation as inhibitors of syn- and anti-protonating glycosidases

The galacto- and gluco-configured imidazopyridines 4 and 5 were synthesised as potential inhibitors of syn-protonating β-glycosidases. Methyl α-D-lyxopyranoside (9) was transformed into the 3,4-anhydro-β-L- riboside 16, which, upon treatment with Et2